An interventional study of Galactic Cap in Male Contraception, Contraceptive Device and Pregnancy Prevention, sponsored by Indiana University. Recruiting at 2 sites in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-18.
Sponsored by Indiana University · Not applicable, Interventional, and Prevention
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
This is a Phase 1 feasibility study evaluating the safety, barrier efficacy, and user acceptability of a novel male contraceptive device, the Galactic Cap (GC), an adhesive, polyurethane-based barrier designed to cover the glans penis. Unlike traditional condoms, the device adheres directly to the penile surface to improve fit, reduce slippage, and enhance sensation through increased skin-to-skin contact and improved heat transfer. The study will enroll 40 monogamous heterosexual couples in which the male partner has undergone vasectomy, allowing assessment of device performance independent of pregnancy risk. Participants will use the device during four separate acts of vaginal intercourse over approximately one month, with data collected via genital examinations, participant diaries, post-use surveys, and pre- and post-coital vaginal swabs analyzed for prostate-specific antigen (PSA) to assess semen leakage. The primary objective is to evaluate safety, with secondary assessment of barrier effectiveness and exploratory evaluation of device performance and user satisfaction compared to traditional condoms.
Indiana University is the lead sponsor of 990 studies on the registry; 201 are open to participants now.
Of its 150 completed or terminated interventional studies of FDA-regulated products, 118 (79%) have results posted.
Counted across the registry records on this site, refreshed daily.
Inclusion Criteria:• Heterosexual couples in monogamous stable relationships (>6 months);
Exclusion Criteria:
Participants will be excluded if they do not meet any of the inclusion criteria. Exclusion criteria comprise:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Increase use of male contraception; Preventing transmission of bodily fluids
Device: Galactic Cap
Use galactic cap four times per week for two weeks
Device Safety
Any potential risk or adverse events associated with device use
Time frame: Day 1 to Day 30
Barrier efficacy
Rate of prostate specific antigen (PSA) detection in post coital vaginal samples
Time frame: Day 7 through day 30
Started Oct 2026 (actual). Primary completion is estimated for Apr 2027, 6 months after the start.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.